| Authors: |
Shahin MS; Division of Gynecologic Oncology, Penn State Hershey Medical Center, Hershey, PA, USA. Electronic address: mshahin@pennstatehealth.psu.edu., Lorusso D; Fondazione Istituto Nazionale Tumori, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Milan, Italy., Backes FJ; Division of Gynecologic Oncology, The Ohio State University, Columbus, OH, USA., Barretina-Ginesta MP; Medical Oncology Department, Institut Català d'Oncologia, Girona Biomedical Research Institute (IDIBGI-CERCA), Girona University, Girona, and Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain., O'Malley DM; The Ohio State University and The James Comprehensive Cancer Center, Columbus, OH, USA., Forget F; Department of Medical Oncology, Hôpital Vivalia De Libramont, Libramont-Chevigny, Belgium., Pothuri B; Departments of Obstetrics/Gynecology and Medicine, Division of Gynecologic Oncology, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA; The GOG Foundation, Philadelphia, PA, USA., Hietanen S; Department of Obstetrics & Gynecology, Turku University Hospital, Turku, Finland., McCormick CC; Legacy Medical Group-Gynecologic Oncology, Portland, OR, USA., Abadie-Lacourtoisie S; Department of Oncology, Institut de Cancérologie de l'Ouest, Site Paul Papin, Angers, France., O'Cearbhaill RE; The GOG Foundation, Philadelphia, PA, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, and Weill Cornell Medical College, New York, NY, USA., Heitz F; Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany, and Department for Gynecology, Center for Oncologic Surgery Charité Campus Virchow-Klinikum, Charité - Universitätsmedizin Berlin; Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin; and Berlin Institute of Health, Berlin, Germany., Moore RG; Division of Gynecologic Oncology, Wilmot Cancer Institute, Department of Obstetrics and Gynecology, University of Rochester, Rochester, NY, USA., Amit A; Gyneco-Oncology Unit, Rambam Health Care Campus, Haifa, and Israeli Society of Gynecologic Oncology (ISGO), Tel Aviv, Israel., Willmott LJ; Arizona Center for Cancer Care, Phoenix, AZ, USA., Pérez MR; Department of Medical Oncology, Reina Sofía University Hospital, Córdoba, and Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain., Burger RA; Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA, USA., Redondo A; Hospital Universitario La Paz - IdiPAZ, Madrid, Spain(.)., Chase DM; Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Romero I; Instituto Valenciano de Oncología, Valencia, Spain., Moore KN; Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA., Vergote I; University Hospitals Leuven, Leuven Cancer Institute, and Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium., Cloven N; Texas Oncology, Fort Worth, TX, USA., Haslund CA; Department of Oncology, Aalborg University Hospital, Aalborg, and Nordic Society of Gynaecological Oncology (NSGO), Copenhagen, Denmark., Graybill WS; Division of Gynecologic Oncology, Medical University of South Carolina, Charleston, SC, USA., Bergamini A; Obstetrics and Gynecology Unit, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milano, Italy., Berton D; Groupe d'Investigateurs National des Études des Cancers Ovariens et du sein (GINECO), Paris, and Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Saint-Herblain, France., Braicu EI; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Department of Gynecology, Charité, Universitätsmedizin Berlin, Berlin, Germany., Lim JT; GSK, Durham, NC, USA., Golembesky AK; GSK, Durham, NC, USA., Shtessel L; GSK, Upper Providence, PA, USA., Monk BJ; The GOG Foundation, Philadelphia, PA, USA; Florida Cancer Specialists & Research Institute, West Palm Beach, FL, USA., González-Martín A; Medical Oncology Department, Translational Oncology Group, CIMA, Universidad de Navarra, Cancer Center Clínica Universidad de Navarra, and Grupo Español de Investigación en Cáncer ginecológicO (GEICO), Madrid, Spain. |
